In the highly regulated biotech industry, ensuring compliance while maintaining operational efficiency is essential for success. This session will feature Egnyte experts showcasing our latest capabilities to support compliance assessment and automation, remediation of compliance risks, and enhanced eTMF management, helping biotech organizations navigate regulatory complexities with greater ease, ensuring data integrity, inspection readiness, and streamlined workflows.

Efficient clinical workflows are key to accelerating drug development while ensuring compliance and data integrity. Join this session, where Egnyte experts will showcase our latest innovations in automation, AI-driven actions, eTMF classification, controlled document management, and content request and collection. With Egnyte’s intelligent automation and compliance capabilities, clinical teams can reduce manual effort, improve accuracy, and streamline document workflows, transforming clinical operations for greater efficiency.

In today’s dynamic biotech environment, success requires navigating an intricate web of science, technology, markets, and regulation—all while pushing the boundaries of innovation. This panel brings together leading CSOs and industry experts to discuss how they balance high-risk, high-reward research with commercialization strategies, talent retention, and regulatory navigation. Join us to explore how emerging technologies, strategic partnerships, and evolving funding models are shaping the future of biotech and how organizations can move efficiently from discovery to patient impact.

Artificial intelligence is reshaping data management across regulated industries, and life sciences is no exception. In this session, Egnyte’s experts will share our vision for AI in life sciences, highlighting how our secure, purpose-built AI engines are enhancing compliance, governance, and collaboration without compromising data privacy. We will explore the evolution of Egnyte’s machine learning models, our commitment to client data security, AI’s growing role across regulated industries, and the potential of AI-driven regulatory intelligence for clinical trials.